FFCP PHASE2:Hg19::chr17:17109579..17109683,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p2@PLD6 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_PLD6_5end |
Coexpression cluster: | C216_osteosarcoma_Smooth_Mesenchymal_large_neuroectodermal_acute_CD34 |
Association with transcript: | 0bp_to_ENST00000321560, ENST00000427497, NM_178836, uc002gqz.2_5end |
EntrezGene: | PLD6 |
HGNC: | 30447 |
UniProt: | Q8N2A8B4DHV4 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@PLD6 |
---|
0
50
100
150
200
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
disease of cellular proliferation | 3.81e-25 | 239 |
cancer | 1.08e-23 | 235 |
organ system cancer | 3.10e-15 | 137 |
hematologic cancer | 2.32e-12 | 51 |
immune system cancer | 2.32e-12 | 51 |
cell type cancer | 4.41e-12 | 143 |
leukemia | 1.05e-11 | 39 |
carcinoma | 4.74e-10 | 106 |
myeloid leukemia | 3.72e-09 | 31 |
neuroectodermal tumor | 2.90e-07 | 10 |
Showing 1 to 10 of 10 entries